Equine CA15-3 antibody and antigen (recombinant protein)

Diagnostic anti-Equine CA15-3 antibodies pairs and antigen for animal health (animal Equine/Horse breast cancer ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-CA15-3-Ag01Equine CA15-3$3090.00
GMP-EQU-CA15-3-Ab01Anti-Equine CA15-3 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CA15-3-Ab02Anti-Equine CA15-3 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CA15-3-Ab03Anti-Equine CA15-3 human monoclonal antibody (mAb)$3090.00
GMP-EQU-CA15-3-Ab04Anti-Equine CA15-3 human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-CA15-3-Ag01
Product NameEquine CA15-3
Target/BiomarkerEquine CA15-3
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine CA15-3 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA15-3 level test of animal Equine/Horse with breast cancer .
TagHis
Reconized/Reactive SpecicsEquine CA15-3
Product descriptionRecombinant Equine CA15-3 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CA15-3-Ab01,GMP-EQU-CA15-3-Ab02
Target/BiomarkerEquine CA15-3
Product NameAnti-Equine CA15-3 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine CA15-3 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA15-3 antibodies in Equine CA15-3 level test of animal Equine/Horse with breast cancer .
Product descriptionAnti-Equine CA15-3 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA15-3 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CA15-3-Ab03,GMP-EQU-CA15-3-Ab04
Target/BiomarkerEquine CA15-3
Product NameAnti-Equine CA15-3 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine CA15-3 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA15-3 antibodies in Equine CA15-3 level test of animal Equine/Horse with breast cancer .
Product descriptionAnti-Equine CA15-3 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Cancer Antigen 15-3 (CA15-3) is a biomarker with significant relevance in the realm of equine biology. Originally characterized in humans, CA15-3 has homologous counterparts in various species, including horses. This glycoprotein assumes a pivotal role in equine physiology, particularly in the context of mammary tissue development and health.

    In mares and potentially in geldings, CA15-3 takes center stage within the intricate landscape of mammary gland physiology. The mammary glands play a critical role in the reproductive biology of mares, serving the essential function of providing nourishment to foals during lactation. Consequently, any disturbances or abnormalities in mammary gland health can have profound implications for equine reproductive capacity and overall well-being.

    CA15-3 is a biomarker that exhibits dynamic expression patterns within the mammary glands of horses. Its levels can vary in response to various physiological factors and changes during different stages of the reproductive cycle, including pregnancy and lactation. These dynamic expressions are closely linked to the regulation of mammary tissue development and function, making CA15-3 a sentinel for the health and integrity of this vital tissue.

    Furthermore, CA15-3 in horses is of particular interest due to its association with mammary tumors, a condition that can affect both mares and geldings. Mammary tumors in horses can vary widely in their characteristics, from benign to malignant, and their early detection and diagnosis are pivotal for timely intervention and improved treatment outcomes. CA15-3 levels have shown promise as a diagnostic tool, with elevated levels often correlating with the presence of mammary tumors and their potential malignancy.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.